Quince Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.779; its P/E ratio is -1.36; Quince Therapeutics is scheduled to report earnings on August 8, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -4.89M	$ -12.50M	$ -6.07M	$ -6.79M	$ -16.26M
EBITDA	$ -4.88M	$ -12.48M	$ -6.03M	$ -6.75M	$ -16.17M
Net Income Common Stockholders	$ -4.89M	$ -12.25M	$ -5.52M	$ -7.92M	$ -16.56M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 64.92M	$ 90.20M	$ 90.18M	$ 94.34M	$ 94.66M
Total Assets	$ 88.84M	$ 93.31M	$ 103.91M	$ 109.78M	$ 117.86M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 420.00K	$ 524.00K
Net Debt	$ -64.92M	$ -90.20M	$ -90.18M	$ -93.92M	$ -94.14M
Total Liabilities	$ 1.95M	$ 3.12M	$ 3.32M	$ 5.25M	$ 6.33M
Stockholders Equity	$ 86.88M	$ 90.22M	$ 100.59M	$ 104.53M	$ 111.53M
Cash Flow	-
Free Cash Flow	$ -3.83M	$ -3.62M	$ -5.91M	$ -6.75M	$ -15.41M
Operating Cash Flow	$ -3.83M	$ -3.57M	$ -5.83M	$ -6.70M	$ -15.41M
Investing Cash Flow	$ -20.32M	$ 5.54M	$ 18.67M	$ -8.83M	$ -5.25M
Financing Cash Flow	$ 26.00K	$ 50.00K	$ -18.00K	$ -5.00K	$ 108.00K

Currency in USD

Quince Therapeutics Earnings and Revenue History

Income Statement >

Quince Therapeutics Debt to Assets

Balance Sheet >

Quince Therapeutics Cash Flow

Cash Flow >

Quince Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing